Dr. Stefanovic-Racic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Fifth Avenue
Falk Clinic, Suite 3b
Pittsburgh, PA 15213Phone+1 412-586-9884Fax+1 412-586-9724
Summary
- Maja Stefanovic-Racic, MD, is an endocrinologist based in Pittsburgh, PA, with subspecialties in diabetes and lipid metabolism. She graduated from the University of Belgrade Faculty of Medicine in 1989 and completed her fellowship in Endocrinology, Diabetes, and Metabolism at UPMC Medical Education in 2004. Her residency and internship were also completed at UPMC Medical Education. Dr. Stefanovic-Racic has several publications in respected journals, primarily focusing on adipose tissue, aging, and metabolic studies. She has notably contributed to research on insulin sensitivity and glycosylated hemoglobin in relation to COVID-19. Additionally, she has been involved in clinical trials such as Muscle Insulin Resistance In Aging and earned the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR in 2011. Since 2015, she has been a Director of the Endocrinology Fellowship Program at the University of Pittsburgh Medical Center.
Education & Training
- UPMC Medical EducationFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
- UPMC Medical EducationResidency, Internal Medicine, 1999 - 2001
- UPMC Medical EducationInternship, Transitional Year, 1998 - 1999
- University of Belgrade Faculty of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 1999 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Muscle Insulin Resistance In Aging Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- Investigating the role of adipose tissue in mobility and aging: design and methods of the Adipose Tissue ancillary to the Study of Muscle, Mobility and Aging (SOMMA-AT).Reichelle X Yeo, Theresa Mau, Zana M Ross, Nicholas P Edenhoffer, Jingfang Liu
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2025-01-31 - 1 citationsMolecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol., John M Jakicic, Wendy M Kohrt, Joseph A Houmard, Michael E Miller
Journal of Applied Physiology. 2024-09-01 - Percutaneous biopsies of skeletal muscle and adipose tissue in individuals older than 70: methods and outcomes in the Study of Muscle, Mobility and Aging (SOMMA).Zeke Zamora, Li-Yung Lui, Lauren M Sparks, Jamie Justice, Mary Lyles
Geroscience. 2024-06-01
Grant Support
- Hepatic Fatty Acid Metabolism And Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: